# Advisor Review - GPT-5.4 (R2)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-10T01:39:35.385493
**Route:** OpenRouter + LaTeX
**Paper Hash:** 7ba174903e62aa4e
**Tokens:** 21794 in / 1664 out
**Response SHA256:** e954203023a38f61

---

I checked the paper only for fatal errors in the four requested categories.

Findings:

- **Data-design alignment:** No fatal mismatch found.  
  - Treatment/policy timing (MEES April 2018; crisis 2021–2023) is covered by the stated data window (2015–October 2023).
  - The before/after windows used for the difference-in-discontinuities design are inside the sample period.
  - The RDD setup uses stated cutoffs that are consistent with the EPC band definitions in the text.

- **Regression sanity:** No fatal regression-output violations found.  
  - No negative SEs, impossible \(R^2\), NA/NaN/Inf results, or obviously exploded coefficients/SEs in the reported price regressions.
  - The larger coefficients in the volume RDD are for a count outcome, so they are not mechanically impossible.

- **Completeness:** No fatal incompleteness found.  
  - Regression tables report standard errors and effective sample sizes.
  - Referenced tables/figures cited in the text appear in the manuscript source.
  - I did not find table cells with TBD/TODO/XXX/NA placeholders in reported results tables.

- **Internal consistency:** No fatal contradiction found.  
  - Minor rounding differences appear (for example McCrary \(p=0.220\) vs \(0.225\), D/E \(0.017\) vs \(0.018\)), but these are not fatal inconsistencies.
  - Reported sample periods and treatment timing are broadly consistent across sections and tables.

ADVISOR VERDICT: PASS